Research Centre for Medical Genetics, Moscow, Russian Federation.
Laboratory of Genetic Epidemiology, Research Centre for Medical Genetics, Moskvorechie St., 1, 115522, Moscow, Russian Federation.
BMC Genomics. 2022 Apr 1;23(1):252. doi: 10.1186/s12864-022-08466-z.
Cystic fibrosis (CF, MIM# 219,700) is an autosomal recessive disease caused by pathogenic variants within the CFTR gene. It was shown that genetic variants located in cis can affect disease severity or treatment response because of additive or epistatic effects. Studies on the prevalence of complex alleles in Russian CF patients have just begun. Aim To evaluate frequencies and genetic background of complex alleles carrying c.1521_1523delCTT (F508del) and c.1399C>T (L467F), c.2562T>G (T854=) or c.4389G>A (Q1463=) in cis; to determine clinical consequences of complex allele c.[1399C>T;1521_1523delCTT] ([L467;F508del]) in Russian CF patients. Methods Sequencing of coding regions of CFTR gene and analysis of polymorphic markers in CF patients carrying F508del variant. Comparing of clinical features in two groups patients having genotypes [L467F;F508del];[F508del] (group 1) and [F508del];[F508del] (group 2). Results Frequency of [L467F;F508del] allele linked to 2-2-21-6-17-13 haplotype was 4.42%, of [F508del;T854=;Q1463=] allele linked to haplotype 1-2-21-6-17-13 - 2.2% in F508del chromosomes. No differences in disease severity in patients carrying complex allele [L467F;F508del] and patients homozygous for F508del was found. Conclusion The frequency of complex alleles associated with F508del was at least 6.6% in Russian CF patients, which should be taken into account for the decision on optimal treatment options with CFTR modulators.
囊性纤维化(CF,MIM#219700)是一种常染色体隐性疾病,由 CFTR 基因中的致病变异引起。已经表明,位于顺式位置的遗传变异由于加性或上位性效应,可以影响疾病的严重程度或治疗反应。关于俄罗斯 CF 患者复杂等位基因的流行率的研究才刚刚开始。目的评估携带 c.1521_1523delCTT(F508del)和 c.1399C>T(L467F)、c.2562T>G(T854=)或 c.4389G>A(Q1463=)的复杂等位基因的频率和遗传背景;确定俄罗斯 CF 患者中顺式携带复杂等位基因 c.[1399C>T;1521_1523delCTT]([L467;F508del])的临床后果。方法对携带 F508del 变异的 CFTR 基因编码区进行测序,并对多态性标记进行分析。比较两组患者的临床特征,一组患者的基因型为[L467F;F508del];[F508del](组 1),另一组患者的基因型为[F508del];[F508del](组 2)。结果与 2-2-21-6-17-13 单倍型相关的[L467F;F508del]等位基因的频率为 4.42%,与单倍型 1-2-21-6-17-13-2 相关的[F508del;T854=;Q1463=]等位基因的频率为 2.2%。在携带复杂等位基因[L467F;F508del]和纯合 F508del 的患者中,未发现疾病严重程度存在差异。结论在俄罗斯 CF 患者中,与 F508del 相关的复杂等位基因的频率至少为 6.6%,在决定 CFTR 调节剂的最佳治疗方案时应考虑这一点。